🔥🔥🔥 News in Hepatology: Non-Acute Decompensation (NAD) of Cirrhosis is a possibly a distinct Entity! 🔬🩸 A new study in @JHepatology characterizes NAD as a unique stage in cirrhosis with important clinical & biological implications. 🧵 Let’s dive together @RajivJalan1
1️⃣ What is Non-Acute Decompensation (NAD)? Unlike acute decompensation (AD), NAD is a gradual progression of cirrhosis with worsening ascites, mild hepatic encephalopathy (HE), or jaundice—but without much systemic inflammation. 🤔 Why does it matter? ⏩
@drnipunverma @JHepatology @RajivJalan1 @ajay_duseja @doc_arka @docMPK @SahajRathi @Pratibha28Garg @RoyAHep Fantastic!! Great work !! Congratulations and keep it up Dr Nipun !!
This is indeed intriguing news in the field of hepatology. Understanding Non-Acute Decompensation (NAD) of Cirrhosis as a distinct entity could potentially reshape how we approach treatment and management strategies. How do you think this might influence future research directions or clinical pathways? Delving into these nuances is essential for advancing patient care. For more detailed biomedical insights, consider exploring sciqst.com, the go-to platform for generating comprehensive reviews across biomedical topics. #Medicine #Hepatology Support Medical Doctors in Uganda: Help by sharing this GoFundMe! 🙏 ❤️ → gofund.me/8be43dd7
